Myconic Capital Corp. (NEO: MEDI) is pleased to announce that effective June 3, 2021 it will change its name to KetamineOne Capital Limited (“Ketamine One” or the “Company”) from Myconic Capital Corp. and do business under the “Ketamine One” brand (the “Name Change”). Concurrently, the Company will transition to a single-purpose company from an investment issuer. Ketamine One will continue to trade under the stock symbol “MEDI” on the NEO Exchange (“NEO”). The Company has also significantly expanded its leadership team with the appointment of a Chief Medical Officer, Chief Research Officer, as well as a President of Clinic Operations.
“We are excited to reveal the re-brand of the Company to Ketamine One, which more accurately reflects our vision to quickly become a leader in the delivery of breakthrough mental wellbeing treatments,” said Adam Deffett, VP of Capital Markets for Ketamine One. “The Company’s new identity is another step in the creation of a network of critical infrastructure needed to safely advance innovative mental wellness treatments and technology, and today’s leadership appointments provide the experience needed to execute on this strategy. Having recently completed two important acquisitions and elevating its operational and strategic strength with additional leadership, Ketamine One is ready to accelerate its plan of aggregating and adding value to medical clinics and research facilities across North America,” added Mr. Deffett.
In accordance with the Name Change, the Company has launched its new website at www.ketamine.one.
(* brand protection nada - ketamineone.com is for sale)
read more (Myconic)
“We are excited to reveal the re-brand of the Company to Ketamine One, which more accurately reflects our vision to quickly become a leader in the delivery of breakthrough mental wellbeing treatments,” said Adam Deffett, VP of Capital Markets for Ketamine One. “The Company’s new identity is another step in the creation of a network of critical infrastructure needed to safely advance innovative mental wellness treatments and technology, and today’s leadership appointments provide the experience needed to execute on this strategy. Having recently completed two important acquisitions and elevating its operational and strategic strength with additional leadership, Ketamine One is ready to accelerate its plan of aggregating and adding value to medical clinics and research facilities across North America,” added Mr. Deffett.
In accordance with the Name Change, the Company has launched its new website at www.ketamine.one.
(* brand protection nada - ketamineone.com is for sale)
read more (Myconic)
Last edited: